Vulvar Lichen Sclerosus: Current Perspectives

References

• Cooper SM, Gao XH, Powell JJ, et al. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol. 2004;140:702–706. doi:10.1001/archderm.140.6.702
   PubMedGoogle Scholar
• Schlosser BJ, Mirowski GW. Lichen sclerosus and lichen planus in women and girls. Clin Obstet Gynecol. 2015;58(1):125–142. doi:10.1097/GRF.0000000000000090
   Web of Science ®Google Scholar
• Goldstein AT, Marinoff SC, Christopher K, et al. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med. 2005;50:477–480.
   PubMed Web of Science ®Google Scholar
• Günthert AR, Faber M, Knappe G, Hellriegel S, Emons G. Early onset vulvar lichen sclerosus in premenopausal women and oral contraceptives. Eur J Obstet Gynecol Reprod Biol. 2008;137(1):56–60. doi:10.1016/j.ejogrb.2007.10.005
   Web of Science ®Google Scholar
• Nair PA. Vulvar Lichen Sclerosus et Atrophicus. J Midlife Health. 2017;8(2):55–62. doi:10.4103/jmh.JMH_13_17
   PubMedGoogle Scholar
• Bleeker MC, Visser PJ, Overbeek LI, Beurden M, Berkhof J. Lichen sclerosus: incidence and risk of vulvar squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2016;25:1224–1230. doi:10.1158/1055-9965.EPI-16-0019
   PubMed Web of Science ®Google Scholar
• Sherman V, McPherson T, Baldo M, Salim A, Gao XH, Wojnarowska F. The high rate of familial lichen sclerosus suggests a genetic contribution: an observational cohort study. J Eur Acad Dermatol Venereol. 2010;24(9):1031–1034. doi:10.1111/j.1468-3083.2010.03572.x
   PubMed Web of Science ®Google Scholar
• Doulaveri G, Armira K, Kouris A, Karypidis D, Potouridou I. Genital vulvar lichen sclerosus in monozygotic twin women: a case report and review of the literature. Case Rep Dermatol. 2013;5:321–325. doi:10.1159/000356775
   Google Scholar
• Lis-Święty A, Mierzwińska K, Wodok-Wieczorek K, Widuchowska M, Brzezińska-Wcisło L. Co-existence of lichen sclerosus and localized scleroderma in female monozygotic twins. J Pediatr Adolesc Gynecol. 2014;27:e133–136. doi:10.1016/j.jpag.2013.11.010
   Google Scholar
• Marren P, Yell J, Charnock FM, Bunce M, Welsh K, Wojnarowska F. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol. 1995;132(2):197–203. doi:10.1111/j.1365-2133.1995.tb05013.x
   PubMed Web of Science ®Google Scholar
• Powell J, Wojnarowska F, Winsey S, Marren P, Welsh K. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol. 2000;142(3):481–484. doi:10.1046/j.1365-2133.2000.03360.x
   PubMed Web of Science ®Google Scholar
• Tran DA, Xiaohui T, Macri CJ, Goldstein AT, Fu SW. Lichen sclerosus: an autoimmunopathologenic and genomic enigma with emerging genetic and immune targets. Int J Biol Sci. 2019;15(7):1429–1439. doi:10.7150/ijbs.34613
   PubMed Web of Science ®Google Scholar
• Gao X-H, Barnardo MCMN, Winsey S, et al. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB1*12 and its associated DRB1*12/DQB1*0301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB1*0301/04 and its associated DRB1*0301/04/DQB1*0201/02/03 haplotype protects from vulval lichen sclerosus. J Invest Dermatol. 2005;125:895–899. doi:10.1111/j.0022-202X.2005.23905.x
   PubMed Web of Science ®Google Scholar
• Meyrick Thomas RH, Ridley CM, McGibbon DH, et al. Lichen sclerosus et atrophicus and autoimmunity: a study of 350 women. Br J Dermatol. 1988;118:41–46. doi:10.1111/bjd.1988.118.issue-1
   PubMed Web of Science ®Google Scholar
• Krapf JM, Goldstein AT. Vulvar lichen sclerosus. The Vulva. 2017;27.
   Google Scholar
• Kreuter A, Kryvosheyeva Y, Terras S, et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients. Acta Derm Venereol. 2013;93:238–241. doi:10.2340/00015555-1512
   PubMed Web of Science ®Google Scholar
• Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol. 2008;144(11):1432–1435. doi:10.1001/archderm.144.11.1432
   PubMedGoogle Scholar
• Kirtschig G, Becker K, Günthert A, et al. Evidence‐based (S3) Guideline on (anogenital) Lichen sclerosus. J Eur Acad Dermatol Venereol. 2015;29(10):e1–e43.
   PubMed Web of Science ®Google Scholar
• Brodrick B, Belkin ZR, Goldstein AT. Influence of treatments on prognosis for vulvar lichen sclerosus: facts and controversies. Clin Dermatol. 2013;31(6):780–786. doi:10.1016/j.clindermatol.2013.05.017
   PubMed Web of Science ®Google Scholar
• Terlou A, Santegoets LAM, van der Meijden WI, et al. An autoimmune phenotype in vulvar lichen sclerosus and lichen planus: a Th1 response and high levels of MicroRNA-155. J Invest Dermatol. 2012;132:658–666. doi:10.1038/jid.2011.369
   PubMed Web of Science ®Google Scholar
• Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol. 2003;21:713–758. doi:10.1146/annurev.immunol.21.120601.140942
   PubMed Web of Science ®Google Scholar
• Ren L, Zhao Y, Huo X, Wu X. MiR-155-5p promotes fibroblast cell proliferation and inhibits FOXO signaling pathway in vulvar lichen sclerosis by targeting FOXO3 and CDKN1B. Gene. 2018;653:43–50. doi:10.1016/j.gene.2018.01.049
   PubMed Web of Science ®Google Scholar
• Chan I. The role of extracellular matrix protein 1 in human skin. Clin Exp Dermatol. 2004;29:52–56. doi:10.1111/ced.2004.29.issue-1
   PubMed Web of Science ®Google Scholar
• Oyama N, Chan I, Neill SM, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. The Lancet. 2003;362(9378):118–123. doi:10.1016/S0140-6736(03)13863-9
   PubMed Web of Science ®Google Scholar
• Godoy CAP, Teodoro WR, Velosa APP, et al. Unusual remodeling of the hyalinization band in vulval lichen sclerosus by type V collagen and ECM 1 protein. Clinics. 2015;70:356–362. doi:10.6061/clinics
   Web of Science ®Google Scholar
• Zhao Y, Zhao S, Li H, Qin X, Wu X. Expression of galectin-7 in vulvar lichen sclerosus and its effect on dermal fibroblasts. Oncol Lett. 2018;16:2559–2564. doi:10.3892/ol.2018.8897
   PubMed Web of Science ®Google Scholar
• Soufir N, Queille S, Liboutet M, et al. Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursors. Br J Dermatol. 2007;156:448–453. doi:10.1111/bjd.2007.156.issue-3
   Web of Science ®Google Scholar
• Goldstein AT Biomarkers of lichen sclerosus NCT03561428. Clinicaltrials.gov. June 2019. Available from: https://clinicaltrials.gov/ct2/show/NCT03561428. Accessed January 3, 2020.
   Google Scholar
• Dalziel KL. Effect of lichen sclerosus on sexual function and parturition. J Reprod Med. 1995;40(5):351–354.
   Web of Science ®Google Scholar
• Gagne H, Dalton V, Haefner H, et al. Vulvar pain and sexual function in patients with lichen sclerosus. J Reprod Med. 2007;52:121–122.
   Google Scholar
• Van de Nieuwenhof H, Meeuwis K, Nieboer T, et al. The effect of vulvar lichen sclerosus on quality of life and sexual functioning. J Psychosom Obstet Gynaecol. 2010;31(4):279–284. doi:10.3109/0167482X.2010.507890
   PubMed Web of Science ®Google Scholar
• Burrows L, Creasey A, Goldstein A. The treatment of vulvar lichen sclerosus and female sexual dysfunction. J Sex Med. 2011;8(1):219–222. doi:10.1111/j.1743-6109.2010.02077.x
   Web of Science ®Google Scholar
• Hodges KR, Wiener CE, Vyas AS, Turrentine MA. The female genital self-image scale in adult women with vulvar lichen sclerosus. J Low Genit Tract Dis. 2019;23(3):210–213. doi:10.1097/LGT.0000000000000481
   PubMed Web of Science ®Google Scholar
• Zendell K, Edwards L. Lichen sclerosus with vaginal involvement: report of 2 cases and review of the literature. JAMA Dermatol. 2013;149(10):1199–1202. doi:10.1001/jamadermatol.2013.4885
   PubMed Web of Science ®Google Scholar
• Longinotti M, Schieffer YM, Kaufman RH. Lichen sclerosus involving the vagina. Obstet Gynecol. 2005;106(5):1217–1219. doi:10.1097/01.AOG.0000161058.02449.e8
   PubMed Web of Science ®Google Scholar
• Ueda Y, Enomoto T, Kimura T, et al. Two distinct pathways to development of squamous cell carcinoma of the vulva. J Skin Cancer. 2011;2011:1–7. doi:10.1155/2011/951250
   Google Scholar
• Bornstein J, Bogliatto F, Haefner HK, et al., ISSVD Terminology Committee. The 2015 International Society for the Study of Vulvovaginal Disease (ISSVD) terminology of vulvar squamous intraepithelial lesions. Obstet Gynecol. 2016;127(2):264–268. doi:10.1097/AOG.0000000000001285
   Web of Science ®Google Scholar
• Vilmer C, Cavelier-Balloy B, Nogues C, Trassard M, Le Doussal V. Analysis of alterations adjacent to invasive vulvar carcinoma and their relationship with the associated carcinoma: a study of 67 cases. Eur J Gynaecol Oncol. 1997;19(1):25–31.
   Web of Science ®Google Scholar
• Bornstein J, Heifetz S, Kellner Y, Stolar Z, Abramovici H. Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus. Am J Obstet Gyn. 1998;178(1):80–84. doi:10.1016/S0002-9378(98)70631-3
   Web of Science ®Google Scholar
• Renaud-Vilmer C, Cavelier-Balloy B, Porcher R, et al. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol. 2004;140:709–712. doi:10.1001/archderm.140.6.709
   PubMedGoogle Scholar
• Bradford J, Fischer G. Long-term management of vulvar lichen sclerosus in adult women. Aust N Zeal J Obstet Gynaecol. 2010;50(2):148–152. doi:10.1111/j.1479-828X.2010.01142.x
   PubMed Web of Science ®Google Scholar
• Lee A, Bradford J, Fischer G. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol. 2015;151(10):1061–1067. doi:10.1001/jamadermatol.2015.0643
   PubMed Web of Science ®Google Scholar
• Neill S, Lewis F, Tatnall F, et al. British association of dermatologists’ guidelines for the management of lichen sclerosus 2010. Br J Dermatol. 2010;163:672–682. doi:10.1111/j.1365-2133.2010.09997.x
   PubMed Web of Science ®Google Scholar
• Lewis FM, Tatnall FM, Velangi SS, et al. British association of dermatologists guidelines for the management of lichen sclerosus 2018. Br J Dermatol. 2018;178:823–824.
   PubMed Web of Science ®Google Scholar
• McCarthy S, MacEoin N, O’Driscoll M, O’Connor R, Heffron CC, Murphy M. Should we always biopsy in clinically evident lichen sclerosus? J Low Genit Tract Dis. 2019;23(2):182–183. doi:10.1097/LGT.0000000000000457
   PubMed Web of Science ®Google Scholar
• Niamh L, Naveen S, Hazel B. Diagnosis of vulval inflammatory dermatoses: a pathological study with clinical correlation. Int J Gynecol Pathol. 2009;28:554–558. doi:10.1097/PGP.0b013e3181a9fb0d
   PubMed Web of Science ®Google Scholar
• Regauer S, Liegl B, Reich O. Early vulvar lichen sclerosus: a histopathological challenge. Histopathology. 2005;47:340–347. doi:10.1111/j.1365-2559.2005.02209.x
   PubMed Web of Science ®Google Scholar
• Murphy R. Lichen sclerosus. Dermatol Clin. 2010;28:707–715. doi:10.1016/j.det.2010.07.006
   Web of Science ®Google Scholar
• Akel R, Fuller C. Updates in lichen sclerosis: British Association of Dermatologists guidelines for the management of lichen sclerosus 2018. Br J Dermatol. 2018;178(4):823–824. doi:10.1111/bjd.16445
   Web of Science ®Google Scholar
• Funaro D, Lovett A, Leroux N, et al. A double- blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus. J Am Acad Dermatol. 2014;71:84–91. doi:10.1016/j.jaad.2014.02.019
   PubMed Web of Science ®Google Scholar
• Ayhan A, Guven S, Guvendag Guven ES, Sakinci M, Gultekin M, Kucukali T. Topical testosterone versus clobetasol for vulvar lichen sclerosus. Int J Gynecol Obstet. 2007;96(2):117–121. doi:10.1016/j.ijgo.2006.09.018
   Web of Science ®Google Scholar
• Terras S, Gambichler T, Moritz RK, et al. UV-A1 phototherapy vs clobetasol propionate, 0.05%, in the treatment of vulvar lichen sclerosus: a randomized clinical trial. JAMA Dermatol. 2014;150:621–627. doi:10.1001/jamadermatol.2013.7733
   PubMed Web of Science ®Google Scholar
• Virgili A, Gorghi A, Toni G, Minghetti S, Corazza M. First randomized trial on clobetasol propionate and mometasone furoate in the treatment of vulvar lichen sclerosus: results of efficacy and tolerability. Br J Dermatol. 2014;171(2):388–396. doi:10.1111/bjd.12910
   PubMed Web of Science ®Google Scholar
• Selk A. A survey of experts regarding the treatment of adult vulvar lichen sclerosus. J Low Genit Tract Dis. 2015;19(3):244–247. doi:10.1097/LGT.0000000000000106
   Web of Science ®Google Scholar
• Andreassi M, Bilenchi R. Topical pimecrolimus in the treatment of genital lichen sclerosus. Expert Rev Derm. 2013;8(5):443–450. doi:10.1586/17469872.2013.835923
   Google Scholar
• Goldstein A, Creasey A, Pfau R, et al. A double blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. J Am Acad Dermatol. 2011;64(6):e99–e104. doi:10.1016/j.jaad.2010.06.011
   Google Scholar
• Lacci KM, Dardik A. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med. 2010;83(1):1.
   PubMedGoogle Scholar
• Sarvajnamurthy S, Suryanarayan S, Budamankuntala L, et al. Autologous platelet rich plasma in chronic venous ulcers: study of 17 cases. J Cutan Aesthet Surg. 2013;6:97–99. doi:10.4103/0974-2077.112671
   Google Scholar
• Yotsu RR, Hagiwara S, Okochi H, et al. Case series of patients with chronic foot ulcers treated with autologous platelet-rich plasma. J Dermatol. 2015;42:288–295. doi:10.1111/1346-8138.12777
   PubMed Web of Science ®Google Scholar
• Wesner M, Defreitas T, Bredy H, et al. A pilot study evaluating the effectiveness of platelet-rich plasma therapy for treating degenerative tendinopathies: a randomized control trial with synchronous observational cohort. PLoS ONE. 2016;11:e0147842. doi:10.1371/journal.pone.0147842
   Web of Science ®Google Scholar
• Wu PI-K, Diaz R, Borg-Stein J. Platelet-rich plasma. Phys Med Rehabil Clin N Am. 2016;27(4):825–853. doi:10.1016/j.pmr.2016.06.002
   PubMed Web of Science ®Google Scholar
• Goldstein AT, King M, Runels C, Gloth M, Pfau R. Intradermal injection of autologous platelet-rich plasma for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol. 2017;76(1):158–160. doi:10.1016/j.jaad.2016.07.037
   PubMed Web of Science ®Google Scholar
• Kim SH, Park ES, Kim TH. Rejuvenation using platelet-rich plasma and lipofilling for vaginal atrophy and lichen sclerosus. J Menopausal Med. 2017;23(1):63–68. doi:10.6118/jmm.2017.23.1.63
   Google Scholar
• Franic D, Iternicka Z, Franic-Ivanisevic M. Platelet-rich plasma (PRP) for the treatment of vulvar lichen sclerosus in premenopausal women: a case report. Case Rep Women’s Health. 2018;16:e00062. doi:10.1016/j.crwh.2018.e00062
   Google Scholar
• Tedesco M, Pranteda G, Chichierchia G, et al. The use of PRP (platelet-rich plasma) in patients affected by genital lichen sclerosus: clinical analysis and results. J Eur Acad Dermatol Venereol. 2019;33(2):e58–e59. doi:10.1111/jdv.2019.33.issue-2
   PubMed Web of Science ®Google Scholar
• Casabona F, Priano V, Vallerino V, et al. New surgical approach to lichen sclerosus of the vulva: the role of adipose-derived mesenchymal cells and platelet-rich plasma in tissue regeneration. Plast Reconstr Surg. 2010;126:210e–211e. doi:10.1097/PRS.0b013e3181ea9386
   PubMed Web of Science ®Google Scholar
• Goldstein AT, Mitchell L, Govind V, Heller D. A randomized double-blind placebo-controlled trial of autologous platelet-rich plasma intradermal injections for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol. 2019;80(6):1788–1789. doi:10.1016/j.jaad.2018.12.060
   PubMed Web of Science ®Google Scholar
• Ozog DM, Rkein AM, Fabi SG, et al. Photodynamic therapy: a clinical consensus guide. Dermatol Surg. 2016;42(7):804–827.
   PubMed Web of Science ®Google Scholar
• Prodromidou A, Chatziioannou E, Daskalakis G, Stergios K, Pergialiotis V. Photodynamic therapy for vulvar lichen sclerosus—a systematic review. J Low Genit Tract Dis. 2018;22(1):58–65. doi:10.1097/LGT.0000000000000362
   PubMed Web of Science ®Google Scholar
• Ruan L, Xie Z, Wang H, et al. High-intensity focused ultrasound treatment for non-neoplastic epithelial disorders of the vulva. Int J Gyn Obstet. 2010;109(2):167–70.\\. doi:10.1016/j.ijgo.2009.12.014
   Web of Science ®Google Scholar
• Sun X, Xue M, Deng X, Wan Y. Clinical factors analysis of curative effect of focused ultrasound treatment for non neoplastic epithelial disorders of the vulva. J Cent Sout Univ. 2010;35(9):933–939.
   Google Scholar
• Ye M, Deng X, Mao S, Xue M. High intensity focused ultrasound treatment for non-neoplastic epithelial disorders of the vulva: factors affecting effectiveness and recurrence. Int J Hyperthermia. 2015;31(7):771–776. doi:10.3109/02656736.2015.1053101
   PubMed Web of Science ®Google Scholar
• Zhou W, Zhu L, Zhou H, et al. The efficacy of high-intensity, focused ultrasound treatment for non-neoplastic epithelial disorders of the vulva. Cell Mol Biol (Noisy-Le-Grand). 2016;62(4):111–115.
   PubMed Web of Science ®Google Scholar
• Lee A, Lim A, Fischer G. Fractional carbon dioxide laser in recalcitrant vulval lichen sclerosus. Australas J Dermatol. 2016;57(1):39–43. doi:10.1111/ajd.12305.
   PubMed Web of Science ®Google Scholar
• Baggish MS. Fractional CO2 laser treatment for vaginal atrophy and vulvar lichen sclerosus. J Gynecol Surg. 2016;32(6):309–317. doi:10.1089/gyn.2016.0099
   Google Scholar
• Center for Vulvovaginal Disorders. MonaLisa touch laser for the treatment of vulvar lichen sclerosus NCT03665584. Clinicaltrials.gov [Internet]. November 2018. Available from: https://clinicaltrials.gov/ct2/show/NCT03665584?cond=lichen+sclerosus&rank=2. Accessed January 3, 2020.
   Google Scholar
• Medstar Health Research Institute. Clobetasol proprionate versus fractionated carbon dioxide laser for the treatment of lichen sclerosus (CuRLS) NCT02573883. Clinicaltrials.gov [Internet]. August 2019. Available from: https://clinicaltrials.gov/ct2/show/NCT02573883. Accessed January 3, 2020.
   Google Scholar
• Hobson JG, Ibrahim SF, Mercurio MG. Recalcitrant vulvar lichen sclerosus treated with erbium YAG laser. JAMA Dermatol. 2019;155(2):254–256. doi:10.1001/jamadermatol.2018.4461
   PubMed Web of Science ®Google Scholar
• Goldstein I. Dorsal slit surgery for clitoral phimosis. Sex Med. 2008;5(11):2485–2488. doi:10.1111/j.1743-6109.2008.01019.x
   PubMed Web of Science ®Google Scholar
• Goldstein A. Perineoplasty and vaginal advancement flap for vulvar granuloma fissuratum. J Sex Med. 2011;8(11):2984–2987. doi:10.1111/j.1743-6109.2011.02528.x
   PubMed Web of Science ®Google Scholar
• Kennedy CM, Dewdney S, Galask RP. Vulvar granuloma fissuratum: a description of fissuring of the posterior fourchette and the repair. Obstet Gynecol. 2005;105(5):1018–1023. doi:10.1097/01.AOG.0000158863.70819.53
   Web of Science ®Google Scholar
• King M, Rubin R, Goldstein AT. Current uses of surgery in the treatment of genital pain. Current Sexual Health Rep. 2014;6(4):252–258. doi:10.1007/s11930-014-0032-8
   Google Scholar
• Goldstein AT, Burrows LJ. Surgical treatment of clitoral phimosis caused by lichen sclerosus. Am J Obstet Gynecol. 2007;196(2):126.e1–4. doi:10.1016/j.ajog.2006.08.023
   Google Scholar
• Flynn A, King M, Rieff M, Krapf J, Goldstein AT. Patient satisfaction of surgical treatment of clitoral phimosis and labial adhesions caused by lichen sclerosus. Sexual Med. 2015;3(4):251. doi:10.1002/sm2.90
   PubMed Web of Science ®Google Scholar
• Rouzier R, Haddad B, Deyrolle C, et al. Perineoplasty for the treatment of introital stenosis related to vulvar lichen sclerosus. Am J Obstet Gynecol. 2002;186:49–52. doi:10.1067/mob.2002.119186
   PubMed Web of Science ®Google Scholar